glp‑1 for alcohol use disorder

GLP-1 reduces heavy drinking days in treatment seeking people with alcohol use disorder and obesity, finds small trial — Phot

Obesity Treatment? GLP‑1 vs Naltrexone Real Difference?

GLP-1 receptor agonists reduce heavy drinking days and promote weight loss more effectively than naltrexone, offering a dual-action therapy for obesity and alcohol use disorder. In a six-week trial, GLP-1 therapy cut heavy drinking days by 62% versus naltrexone. Medical Disclaimer: This article is for informational purposes only and does